Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

NCT02173093 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Disseminated Neuroblastoma
Recurrent Neuroblastoma

Interventions

BIOLOGICAL: IL-2
BIOLOGICAL: GD2Bi-aATC
BIOLOGICAL: GM-CSF
OTHER: laboratory evaluations of immune responses

Sponsor

University of Virginia

Collaborators

[object Object]